Zaiding Pharmaceutical (09688.HK) plans to hold a board meeting on May 9 (Hong Kong time) to approve the first quarter results

Gelonghui, April 26, 丨 Zaiding Pharmaceutical (09688.HK) announced that the Board Review Committee will review and approve (including) the unaudited quarterly results (“First Quarter Results”) of the Company and its subsidiaries for the 3 months ended March 31, 2024, prepared in accordance with US GAAP and applicable rules of the US Securities and Exchange Commission (“First Quarter Results”). If the first quarter results are approved by the Audit Committee, the company will do so on Wednesday, May 8, 2024 (US)

Gelonghui Finance04:52 ET

再鼎醫藥：審核委員會行動通告及2024年第一季度業績公告的發佈日期

Futu News04:42 ET · Announcements

Zai Lab Files Automatic Ordinary Shares Offering

Seeking AlphaApr 19 17:20 ET

Express News | Zai Lab Ltd : JP Morgan Cuts Target Price to $38 From $44

Moomoo 24/7Apr 17 23:23 ET

Asian Equities Traded in the US as American Depositary Receipts Remain Flat in Wednesday Trading

After opening the trading session in positive territory, Asian equities traded in the US as American depositary receipts fell flat Wednesday morning, declining 0.061% to 1,823.73 on the S&P Asia 50 AD

MT NewswiresApr 17 10:58 ET

Press Release: Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024

Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024 - Company to Host Conference Call and Webcast on May 9, 2024, at 8:00 a.m. ET (8:00 p.m. HKT) SHA

Dow JonesApr 15 07:30 ET